Green Cross to supply $12M worth of flu vaccines to PAHO; Australian government orders anti-vaccine group to change name;

 @AlisonBFierce: Sanofi Pasteur MSD's recall of its typhoid vaccine has led to a shortage in the U.K. More | Follow @AlisonBFierce

> Dr. Gary R. Matyas won $5 million from the National Institute on Drug Abuse to develop a vaccine against HIV that also prevents heroin addiction. Story

> South Korea's Green Cross won a contract to supply $12 million worth of flu vaccines to the Pan American Health Organization. News

> The Australian government ordered an anti-vaccine group to change its name because it "poses a serious risk of misleading the community." Report

> Cuba patented a new lung cancer vaccine, dubbed Racotumomab. Article

And Finally... Immunovaccine reported positive results from an ongoing study of DepoVax-based anthrax vaccines. Release

Suggested Articles

CEPI, which started to help prepare the world for new outbreaks, has awarded Inovio and Moderna money for vaccine work against the new coronavirus.

As a new coronavirus spreads, vaccine researchers have started work on candidates against the virus—and one could enter the clinic in a few months.

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.